Daily Ards Research Analysis
Analyzed 3 papers and selected 3 impactful papers.
Summary
Analyzed 3 papers and selected 3 impactful articles.
Selected Articles
1. Utilization of Neuromuscular Blocking Agents in Acute Brain Injury and Associations with Outcomes: A Post Hoc Analysis of the ENIO Study.
Post hoc analysis of a multicenter prospective observational study (ENIO) found wide international variation in NMBA use among ventilated acute brain injury patients; NMBA use (matched cohort n=258) was more common in patients with intraparenchymal ICP monitoring and external ventricular drains and in those with moderate-to-severe ARDS. Authors call for randomized trials to clarify outcome effects.
Impact: Identifies large practice variation and specific clinical correlates of NMBA use in ABI—data that can inform trial design and highlight an understudied area with potential implications for both neurologic and respiratory outcomes.
Clinical Implications: Current practice varies widely; clinicians should be aware that NMBA are more often used in patients with ICP monitoring or moderate-to-severe ARDS. This supports equipoise for randomized trials to determine whether NMBA improve neurologic or respiratory outcomes in ABI.
Key Findings
- Propensity-matched cohort (n=258) showed 33.3% received NMBA during first ICU week.
- Marked international variation in NMBA utilization (0%–59.3% across countries).
- NMBA use was associated with intraparenchymal ICP monitoring (OR 2.06) and external ventricular drain placement (OR 2.18); most frequently used in patients with moderate-to-severe ARDS.
Methodological Strengths
- Multicenter, prospective observational design (ENIO) with large initial sample for propensity analysis (n=1482).
- Use of propensity score matching to reduce confounding and multivariable regression to identify associations.
Limitations
- Post hoc observational analysis cannot establish causality; residual confounding possible despite propensity matching.
- Some data elements truncated or missing in abstract (e.g., PaCO2 result unavailable here); heterogeneity across centers may limit generalizability.
Future Directions: Randomized controlled trials comparing NMBA use versus no NMBA in ventilated ABI patients, stratified by presence of ICP monitoring and ARDS severity, and mechanistic studies on NMBA effects on cerebral physiology and lung protection.
BACKGROUND: Neuromuscular blocking agents (NMBA) have been used in mechanically ventilated patients with moderate-to-severe acute respiratory distress syndrome (ARDS), in cases of clinically significant ventilator dyssynchrony, and in patients with elevated intracranial pressure (ICP). However, practice patterns around NMBA utilization and their impact on outcomes in acute brain injury (ABI) remain insufficiently explored. METHODS: This study carried out a post hoc analysis of a multicenter, prospective observational study (NCT03400904) including adult patients with ABI (Glasgow Coma Scale ≤ 12 before intubation) who required invasive mechanical ventilation (IMV) ≥ 24 h. Patients who received NMBA during their first week of ICU stay were propensity matched to those who did not. RESULTS: Propensity score matching was performed in 1482 patients; among the matched cohort (n = 258), 33.3% (n = 86) received NMBA. NMBA utilization varied from 0% to 59.3% across countries. Multivariable regressions demonstrated associations between NMBA use and utilization of intraparenchymal ICP monitoring (odds ratio, OR 2.06; 95% confidence interval, CI 1.16-3.76), extraventricular drain placement (OR 2.18; 95% CI 1.18-4.05), higher PaCO CONCLUSIONS: NMBA utilization varied widely, highlighting the need for more evidence to guide clinical practice. NMBA were most commonly used in patients with ICP monitoring or moderate-to-severe ARDS; associations with outcomes warrant further exploration in randomized controlled trials.
2. Lung-protective mechanical ventilation is not sex neutral.
This perspective argues that lung‑protective ventilation (low tidal volume based on predicted body weight) is not sex‑neutral: women with ARDS receive lung protection less often due to height estimation errors and may derive less benefit because current formulas do not capture sex‑specific respiratory physiology and extrapulmonary differences.
Impact: Highlights an underappreciated source of inequity and potential harm in mechanical ventilation practice and points to simple modifiable factors (accurate height/weight measurement, sex‑aware targets) that could improve outcomes.
Clinical Implications: Clinicians should measure height rather than estimate it, consider sex when calculating predicted body weight and tidal volumes, and be aware that guideline targets may underprotect some female patients—prompting audits and possible protocol adjustments.
Key Findings
- Women with ARDS have higher mortality and are less likely to receive lung-protective ventilation due to shorter stature and visual height estimation errors.
- Standard predicted body weight formulas and tidal volume targets may not capture sex-specific respiratory physiology, potentially reducing efficacy in females.
- Non-pulmonary sex differences in critical illness management further compound differential outcomes.
Methodological Strengths
- Synthesizes clinical observations and physiology to identify an actionable problem (measurement bias and physiologic mismatch).
- Brings attention to sex as an important variable in ventilator management, prompting quality improvement and research.
Limitations
- Not a primary data study—primarily a perspective/narrative synthesis without new empirical data in this paper.
- Specific quantitative estimates and effect sizes are not provided here; implementation impact requires empirical validation.
Future Directions: Prospective audits and interventional trials testing measured height/weight protocols, sex‑adjusted predicted body weight formulas, and outcomes by sex; mechanistic studies of sex differences in lung mechanics and ventilator‑induced lung injury.
Ventilator-induced lung injury can be mitigated with a lung-protective ventilation strategy that includes ventilation with low tidal volumes. Mortality in acute respiratory distress syndrome (ARDS) remains higher in females than in males, and females with ARDS are less likely to receive lung-protective ventilation compared with males because of their shorter height and greater error when body height is visually estimated. In addition, lung-protective ventilation might be less effective in females because of differences in respiratory physiology not accounted for by the formula commonly used to assess body weight, and because of several clinically important sex-specific differences in extrapulmonary biology and management of critical illness.
3. Delayed acute respiratory distress syndrome and sepsis-associated disseminated intravascular coagulation following aluminium phosphide poisoning.
Single adolescent case of aluminium phosphide ingestion developed delayed (72–96 h) moderate ARDS with culture‑proven infections, sepsis, and DIC, requiring escalation to invasive mechanical ventilation with lung‑protective strategies and targeted supportive care, and ultimately achieved full recovery. Highlights late pulmonary complications after phosphide poisoning and the potential for survival with protocolized care.
Impact: Although a single case, it documents a rare but clinically important delayed pulmonary complication (ARDS with sepsis/DIC) after aluminium phosphide poisoning and demonstrates that aggressive, protocolized supportive care can lead to survival.
Clinical Implications: Clinicians treating phosphide poisoning should monitor for delayed respiratory deterioration and secondary infections up to several days after ingestion; early escalation to lung‑protective invasive ventilation and management of sepsis/DIC may be lifesaving.
Key Findings
- Patient developed delayed moderate ARDS (PaO2/FiO2 ≈115 on FiO2 1.0) 72–96 hours after ingestion, preceded by fever and culture-proven lower respiratory and urinary infections.
- Clinical course included escalation from non-invasive to invasive mechanical ventilation with lung-protective strategies, targeted antibiotics, DIC component therapy, and electrolyte supplementation (Mg, Ca).
- Despite high NT‑proBNP and transient AKI, preserved biventricular function and protocolized supportive care led to full recovery and discharge with normal oxygenation.
Methodological Strengths
- Detailed temporal clinical timeline illustrating delayed complications and interventions.
- Clear description of supportive measures and favorable outcome despite severe complications—valuable for rare-event clinical guidance.
Limitations
- Single case report limits generalizability and cannot establish incidence or causal mechanisms.
- Lack of mechanistic studies (e.g., histopathology, advanced pulmonary imaging) limits understanding of precise pathophysiology.
Future Directions: Case series or registry data to define incidence and risk factors for delayed ARDS after phosphide poisoning; mechanistic studies on phosphine-induced pulmonary injury and optimal timing of interventions.
Aluminium phosphide is a highly lethal pesticide that liberates phosphine gas, leading to mitochondrial dysfunction, distributive shock and cardiotoxicity, but guidance on late pulmonary complications is limited. We report a previously healthy adolescent who ingested ~1.5 g of aluminium phosphide in a suicide attempt and initially presented haemodynamically stable with metabolic acidosis and elevated lactate. By 72-96 hours, she developed progressive hypoxemic respiratory failure with bilateral infiltrates fulfilling Berlin criteria for moderate acute respiratory distress syndrome (ARDS) (PaO₂/FiO₂ nadir ≈115 on FiO₂ 1.0), preceded by fever and culture-proven lower respiratory and urinary tract infections, resulting in sepsis and disseminated intravascular coagulation (DIC). She required escalation from non-invasive to invasive mechanical ventilation, with lung-protective strategies, targeted antibiotics, component therapy for DIC and early magnesium and calcium supplementation. Despite markedly elevated N-terminal pro-B-type natriuretic peptide with preserved biventricular function on echocardiography and transient acute kidney injury, she made a full clinical recovery and was discharged with normal oxygenation and functional status. This case underscores that delayed moderate ARDS with superimposed sepsis and DIC can complicate initially stable aluminium phosphide poisoning and highlights that meticulous, protocol-based supportive care can still result in survival in this rarely reported scenario.